Komori
Pharma Foods International (2929) · RiskFirst stated

Sales Trends for New Products and Changes in Consumer Preferences

First written in FY2021. . Latest entry: FY2021.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Risk that original and new products fail to achieve market acceptanceA theme 29 companies write about · 29 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 3 of 7 companies on the "Worse" side.

3 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 29 companies compared. The sentences above are computed from all 29.
Full recordFilings, disclosures and news, newest first
  1. FY2021First statedAnnual report

    「The functional foods, health foods, cosmetics and other products sold by the Group are easily affected by consumer preferences and tend to have relatively short product life cycles.」

    The company identifies as risks the products’ sensitivity to consumer preferences and short life cycles, as well as the potential impact on performance if new product development and expansion into application areas do not proceed as planned.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.